RxDoctor Payments Data

Courtney Streeto, APRN

Psychiatric/Mental Health · Avon, CTNPI 1023627726

Payments from drug & device makers

$947in general payments, 2019–2025

Across 46 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$419
  • Neurocrine Biosciences, Inc.$291
  • Otsuka America Pharmaceutical, Inc.$47
  • Avanir Pharmaceuticals, Inc.$37
  • Lundbeck LLC$35
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$947 in reported general payments places this provider in the 65th percentile of 679 psychiatric/mental health providers in Connecticut.

See all psychiatric/mental health providers in Connecticut

Medicare billing

Part B allowed, 2024
$119,233
Medicare patients
312
Services billed
1,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trazodone Hcl138$2,109
Mirtazapine77$1,956
Lorazepam89$1,744
Risperidone29$953
Duloxetine Hcl36$903
Quetiapine Fumarate23$879
Sertraline Hcl64$744
Clonazepam31$738
Alprazolam27$653
Divalproex Sodium12$638
Escitalopram Oxalate26$421
Memantine Hcl13$382
Venlafaxine Hcl ErVenlafaxine Hcl14$362

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Avon

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →